dc.relation.reference | Thesis 1. Adverse Birth Outcomes near Municipal Waste Incinerators in Taiwan
1. IARC. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC Mon Eval Carcinog Risks Hum 1997;69:33-343.
2. Grassman JA, Masten SA, Walker NJ, Lucier GW. Animal models of human response to dioxins. Environ Health Perspect 1998;106:761-75.
3. Schecter A, Kassis I, Papke O. Partitioning of dioxins, dibenzofurans, and coplanar PCBS in blood, milk, adipose tissue, placenta and cord blood from five American women. Chemosphere 1998;37:1817-23.
4. Eskenazi B, Mocarelli P, Warner M, Chee WY, Gerthoux PM, Samuels S, et al. Maternal serum dioxin levels and birth outcomes in women of Seveso, Italy. Environ Health Perspect 2003;111:947-53.
5. Revich B, Aksel E, Ushakova T, Ivanova I, Zhuchenko N, Klyuev N, et al. Dioxin exposure and public health in Chapaevsk, Russia. Chemosphere 2001;43:951-66.
6. Moshammer H, Neuberger M. Sex ratio in the children of the Austrian chloracne cohort. Lancet 2000;356:1271-2.
7. Schnorr TM, Lawson CC, Whelan EA, Dankovic DA, Deddens JA, Piacitelli LA, et al. Spontaneous abortion, sex ratio, and paternal occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ Health Perspect 2001;109:1127-32.
8. Yoshimura T, Kaneko S, Hayabuchi H. Sex ratio in offspring of those affected by dioxin and dioxin-like compounds: the Yusho, Seveso, and Yucheng incidents. Occup Environ Med 2001;58:540-1.
9. Ryan JJ, Amirova Z, Carrier G. Sex ratios of children of Russian pesticide producers exposed to dioxin. Environ Health Perspect 2002;110:A699-701.
10. Lai YL. Health Risk Assessment on Incinerator-Emitted Dioxins in Taiwan. National Taiwan University College of Public Health, 2001.
11. USEPA. Human health and ecological risk assessment support to the development of technical standards for emissions from combustion units burning hazardous wastes: background document. 1999:EPA/68/w6/0053.
12. USEPA. User's Guide for the Industrial Source Complex (ISC3) Dispersion Models, Vol. I - User Instructions and Vol. II - Description of Model Algorithms. United States Environmental Protection Agency. Office of Air Quality Planning and Standards, September, EPA-454/B-95-003a,b., 1995.
13. Hsieh W, Wu H, Jeng S, Liao H, Su Y, Lin S, et al. Nationwide Singleton Birth Weight Percentiles by Gestational Age in Taiwan, 1998-2002. Acta Paediatr Tw 2006;47:25-33.
14. Courtney KD. Mouse teratology studies with chlorodibenzo-p-dioxins. Bull Environ Contam Toxicol 1976;16:674-81.
15. Allen JR, Barsotti DA, Lambrecht LK, Van Miller JP. Reproductive effects of halogenated aromatic hydrocarbons on nonhuman primates. Ann N Y Acad Sci 1979;320:419-25.
16. Murray FJ, Smith FA, Nitschke KD, Humiston CG, Kociba RJ, Schwetz BA. Three-generation reproduction study of rats given 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the diet. Toxicol Appl Pharmacol 1979;50:241-52.
17. Nau H, Bass R, Neubert D. Transfer of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) via placenta and milk, and postnatal toxicity in the mouse. Arch Toxicol 1986;59:36-40.
18. Umbreit TH, Hesse EJ, Gallo MA. Reproductive toxicity in female mice of dioxin-contaminated soils from a 2,4,5-trichlorophenoxyacetic acid manufacturing site. Arch Environ Contam Toxicol 1987;16:461-6.
19. Bjerke DL, Sommer RJ, Moore RW, Peterson RE. Effects of in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on responsiveness of the male rat reproductive system to testosterone stimulation in adulthood. Toxicol Appl Pharmacol 1994;127:250-7.
20. Eskenazi B, Kimmel G. Workshop on perinatal exposure to dioxin-like compounds. II. Reproductive effects. Environ Health Perspect 1995;103:143-5.
21. Mastroiacovo P, Spagnolo A, Marni E, Meazza L, Bertollini R, Segni G, et al. Birth defects in the Seveso area after TCDD contamination. JAMA 1988;259:1668-72.
22. Mocarelli P, Brambilla P, Gerthoux PM, Patterson DG J, Needham LL. Change in sex ratio with exposure to dioxin. Lancet 1996;348:409.
23. Mocarelli P, Gerthoux PM, Ferrari E, Patterson DG J, Kieszak SM, Brambilla P, et al. Paternal concentrations of dioxin and sex ratio of offspring. Lancet 2000;355:1858-63.
24. Lin CM, Li CY, Mao IF. Ambient dioxin exposure to incinerators inassociation with adverse birth outcomes. Taiwan J Public Health 2002;21:197-206.
25. Tango T, Fujita T, Tanihata T, Minowa M, Doi Y, Kato N, et al. Risk of adverse reproductive outcomes associated with proximity to municipal solid waste incinerators with high dioxin emission levels in Japan. J Epidemiol 2004;14:83-93.
26. Fries GF, Paustenbach DJ. Evaluation of potential transmission of 2,3,7,8-tetrachlorodibenzo-p-dioxin-contaminated incinerator emissions to humans via foods. J Toxicol Environ Health 1990;29:1-43.
27. Eschenroeder A, Lorber M. An evaluation of EPA's ISCST-version 3 model part1. Air dispersion of dioxins. Organohalogen Compounds 1999;41:547-52.
28. Lorber M, Eschenroeder A, Robinson R. Testing the USA EPA's ISCST-Version 3 model on dioxins: a comparison of predicted and observed air and soil concentrations. Atmospheric Environment 2000;34:3995-4010.
29. Dejin-Karlsson E, Ostergren PO. Psychosocial factors, lifestyle, and fetal growth: the added value of both pre- and post-natal assessments. Eur J Public Health 2003;13:210-7.
30. Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol 2000;5:231-41.
31. Lindbohm ML, Sallmen M, Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health. Scand J Work Environ Health 2002;28:84-96.
32. Fortier I, Marcoux S, Brisson J. Passive smoking during pregnancy and the risk of delivering a small-for-gestational-age infant. Am J Epidemiol 1994;139:294-301.
33. Windham GC, Hopkins B, Fenster L, Swan SH. Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology 2000;11:427-33.
34. Chen PC, Doyle PE, Pain L, Wang JD. Parental socioeconomic status and low birthweight, preterm delivery, and small for gestational age in Taiwan. Chin J Public Health 1999;18:105-115.
35. Wen CP, Levy DT, Cheng TY, Hsu CC, Tsai SP. Smoking behaviour in Taiwan, 2001. Tob Control 2005;14:i51-5.
Theses 2. Cotinine, Genetic Polymorphism, and Infant Growth and Neurobehavioral Development
1. Suzuki K, Minei LJ, Johnson EE. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol 1980;136:1009-13.
2. Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol 2000;5:231-41.
3. Lindbohm ML, Sallmen M, Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health. Scand J Work Environ Health 2002;28:84-96.
4. Windham GC, Hopkins B, Fenster L, Swan SH. Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology 2000;11:427-33.
5. Fortier I, Marcoux S, Brisson J. Passive smoking during pregnancy and the risk of delivering a small-for-gestational-age infant. Am J Epidemiol 1994;139:294-301.
6. Slotkin TA. Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther 1998;285:931-45.
7. Chiriboga CA. Fetal alcohol and drug effects. Neurologist 2003;9:267-79.
8. Law KL, Stroud LR, LaGasse LL, Niaura R, Liu J, Lester BM. Smoking during pregnancy and newborn neurobehavior. Pediatrics 2003;111:1318-23.
9. Godding V, Bonnier C, Fiasse L, Michel M, Longueville E, Lebecque P, et al. Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates? Pediatr Res 2004;55:645-51.
10. Benowitz NL, Jacob P, 3rd. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994;56:483-93.
11. Benowitz NL, Jacob P, 3rd. Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br J Clin Pharmacol 2001;51:53-9.
12. Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 1999;107:349-55.
13. Bjercke RJ, Cook G, Rychlik N, Gjika HB, Van Vunakis H, Langone JJ. Stereospecific monoclonal antibodies to nicotine and cotinine and their use in enzyme-linked immunosorbent assays. J Immunol Methods 1986;90:203-13.
14. Jaakkola MS, Ma J, Yang G, Chin MF, Benowitz NL, Ceraso M, et al. Determinants of salivary cotinine concentrations in Chinese male smokers. Prev Med 2003;36:282-90.
15. Pascual JA, Diaz D, Segura J, Garcia-Algar O, Vall O, Zuccaro P, et al. A simple and reliable method for the determination of nicotine and cotinine in teeth by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 2003;17:2853-5.
16. Cognard E, Staub C. Determination of nicotine and its major metabolite cotinine in plasma or serum by gas chromatography-mass spectrometry using ion-trap detection. Clin Chem Lab Med 2003;41:1599-607.
17. Page-Sharp M, Hale TW, Hackett LP, Kristensen JH, Ilett KF. Measurement of nicotine and cotinine in human milk by high-performance liquid chromatography with ultraviolet absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci 2003;796:173-80.
18. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, et al. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin Chem 2002;48:1460-71.
19. Bentley MC, Abrar M, Kelk M, Cook J, Phillips K. Validation of an assay for the determination of cotinine and 3-hydroxycotinine in human saliva using automated solid-phase extraction and liquid chromatography with tandem mass spectrometric detection. J Chromatogr B Biomed Sci Appl 1999;723:185-94.
20. Hukkanen J, Jacob P, 3rd, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005;57:79-115.
21. Cashman JR, Zhang J. Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation. Drug Metab Dispos 2002;30:1043-52.
22. Wiener D, Fang JL, Dossett N, Lazarus P. Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes. Cancer Res 2004;64:1190-6.
23. Villeneuve L, Girard H, Fortier LC, Gagne JF, Guillemette C. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs. J Pharmacol Exp Ther 2003;307:117-28.
24. Eaton DL, Bammler TK. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999;49:156-64.
25. McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006;25:1639-48.
26. Ghobadloo SM, Yaghmaei B, Bakayev V, Goudarzi H, Noorinayer B, Rad FH, et al. GSTP1, GSTM1, and GSTT1 genetic polymorphisms in patients with cryptogenic liver cirrhosis. J Gastrointest Surg 2004;8:423-7.
27. Tamer L, Ercan B, Camsari A, Yildirim H, Cicek D, Sucu N, et al. Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic Res Cardiol 2004;99:223-9.
28. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett 2005;221:123-9.
29. Tamer L, Ates NA, Ates C, Ercan B, Elipek T, Yildirim H, et al. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct 2005;23:267-72.
30. Kim WJ, Kim H, Kim CH, Lee MS, Oh BR, Lee HM, et al. GSTT1-null genotype is a protective factor against bladder cancer. Urology 2002;60:913-8.
31. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000;463:247-83.
32. Seidegard J, Ekstrom G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 1997;105:791-9.
33. Pal A, Hu X, Zimniak P, Singh SV. Catalytic efficiencies of allelic variants of human glutathione S-transferase Pi in the glutathione conjugation of alpha, beta-unsaturated aldehydes. Cancer Lett 2000;154:39-43.
34. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, Schwartz BS, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 1995;16:1243-5.
35. Wang J, Deng Y, Cheng J, Ding J, Tokudome S. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 2003;201:185-93.
36. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998;19:275-80.
37. Gilliland FD, Li YF, Dubeau L, Berhane K, Avol E, McConnell R, et al. Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 2002;166:457-63.
38. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002;287:195-202.
39. Nukui T, Day RD, Sims CS, Ness RB, Romkes M. Maternal/newborn GSTT1 null genotype contributes to risk of preterm, low birthweight infants. Pharmacogenetics 2004;14:569-76.
40. Hong YC, Lee KH, Son BK, Ha EH, Moon HS, Ha M. Effects of the GSTM1 and GSTT1 polymorphisms on the relationship between maternal exposure to environmental tobacco smoke and neonatal birth weight. J Occup Environ Med 2003;45:492-8.
41. Morgan AM, Koch V, Lee V, Aldag J. Neonatal neurobehavioral examination. A new instrument for quantitative analysis of neonatal neurological status. Phys Ther 1988;68:1352-8.
42. Jeng SF, Tsao CC, Chen LC, Teng RJ, Yau KI, Jan MH. Reliability of the Neonatal Neurobehavioral Examination--Chinese version. Early Hum Dev 1996;45:191-202.
43. Wang TM SC, Liao HF, Lin LY, Chou KS, Lin SH. The Standardization of The Comprehensive Developmental Inventory for Infants and Toddlers. Psychological Testing 1998;45:19-46.
44. Liao HF, Pan YL. Test-retest and inter-rater reliability for the Comprehensive Developmental Inventory for Infants and Toddlers diagnostic and screening tests. Early Hum Dev 2005;81:927-37.
45. Cadwell BM BR. HOME Inventory Administration Manual, 2003.
46. Bradley RH, Caldwell BM. Using the home inventory to assess the family environment. Pediatr Nurs 1988;14:97-102.
47. Kharrazi M, DeLorenze GN, Kaufman FL, Eskenazi B, Bernert JT, Jr., Graham S, et al. Environmental tobacco smoke and pregnancy outcome. Epidemiology 2004;15:660-70.
48. Donnenfeld AE, Pulkkinen A, Palomaki GE, Knight GJ, Haddow JE. Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol 1993;168:781-2.
49. Comstock KE, Sanderson BJ, Claflin G, Henner WD. GST1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res 1990;18:3670.
50. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-6.
51. Peacock JL, Cook DG, Carey IM, Jarvis MJ, Bryant AE, Anderson HR, et al. Maternal cotinine level during pregnancy and birthweight for gestational age. Int J Epidemiol 1998;27:647-56.
52. Bardy AH, Seppala T, Lillsunde P, Kataja JM, Koskela P, Pikkarainen J, et al. Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking. Br J Obstet Gynaecol 1993;100:721-6.
53. Kaufman FL, Kharrazi M, Delorenze GN, Eskenazi B, Bernert JT. Estimation of environmental tobacco smoke exposure during pregnancy using a single question on household smokers versus serum cotinine. J Expo Anal Environ Epidemiol 2002;12:286-95.
54. DeLorenze GN, Kharrazi M, Kaufman FL, Eskenazi B, Bernert JT. Exposure to environmental tobacco smoke in pregnant women: the association between self-report and serum cotinine. Environ Res 2002;90:21-32.
55. Pichini S, Basagana XB, Pacifici R, Garcia O, Puig C, Vall O, et al. Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy. Environ Health Perspect 2000;108:1079-83.
56. Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med 2002;166:710-6.
57. Bayley N. Manual of Bayley Scales of Infant Development. 1969.
58. Liao HF, Wang TM, Yao G, Lee WT. Concurrent validity of the Comprehensive Developmental Inventory for Infants and Toddlers with the Bayley Scales of Infant Development-II in preterm infants. J Formos Med Assoc 2005;104:731-7.
59. Eskenazi B, Castorina R. Association of prenatal maternal or postnatal child environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. Environ Health Perspect 1999;107:991-1000.
60. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 1996;275:1233-40.
61. Government Information Office, Taiwan. http://www.gio.gov.tw/info/taiwan-story/society/down/3-4.htm. | en |